Division of Infectious Diseases, Department of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Clin Infect Dis. 2023 Mar 21;76(6):1080-1087. doi: 10.1093/cid/ciac853.
Cryptococcal meningitis is a common cause of AIDS-related mortality. Although symptom recurrence after initial treatment is common, the etiology is often difficult to decipher. We sought to summarize characteristics, etiologies, and outcomes among persons with second-episode symptomatic recurrence.
We prospectively enrolled Ugandans with cryptococcal meningitis and obtained patient characteristics, antiretroviral therapy (ART) and cryptococcosis histories, clinical outcomes, and cerebrospinal fluid (CSF) analysis results. We independently adjudicated cases of second-episode meningitis to categorize patients as (1) microbiological relapse, (2) paradoxical immune reconstitution inflammatory syndrome (IRIS), (3) persistent elevated intracranial pressure (ICP) only, or (4) persistent symptoms only, along with controls of primary cryptococcal meningitis. We compared groups with chi-square or Kruskal-Wallis tests as appropriate.
724 participants were included (n = 607 primary episode, 81 relapse, 28 paradoxical IRIS, 2 persistently elevated ICP, 6 persistent symptoms). Participants with culture-positive relapse had lower CD4 (25 cells/μL; IQR: 9-76) and lower CSF white blood cell (WBC; 4 cells/μL; IQR: 4-85) counts than paradoxical IRIS (CD4: 78 cells/μL; IQR: 47-142; WBC: 45 cells/μL; IQR: 8-128). Among those with CSF WBC <5 cells/μL, 86% (43/50) had relapse. Among those with CD4 counts <50 cells/μL, 91% (39/43) had relapse. Eighteen-week mortality (from current symptom onset) was 47% among first episodes of cryptococcal meningitis, 31% in culture-positive relapses, and 14% in paradoxical IRIS.
Poor immune reconstitution was noted more often in relapse than IRIS as evidenced by lower CSF WBC and blood CD4 counts. These easily obtained laboratory values should prompt initiation of antifungal treatment while awaiting culture results.
NCT01802385.
隐球菌性脑膜炎是艾滋病相关死亡的常见原因。虽然初始治疗后症状复发很常见,但病因往往难以确定。我们旨在总结第二次有症状复发患者的特征、病因和结局。
我们前瞻性纳入了患有隐球菌性脑膜炎的乌干达人,并获取了患者特征、抗逆转录病毒治疗(ART)和隐球菌病病史、临床结局以及脑脊液(CSF)分析结果。我们独立判断第二次脑膜炎发作的病例,将患者分为(1)微生物学复发,(2)矛盾性免疫重建炎症综合征(IRIS),(3)仅持续性颅内压升高(ICP),或(4)仅持续性症状,并与原发性隐球菌性脑膜炎的对照组进行比较。我们使用卡方检验或 Kruskal-Wallis 检验进行组间比较。
共纳入 724 名参与者(原发性隐球菌性脑膜炎 607 例,复发 81 例,矛盾性 IRIS 28 例,持续性 ICP 升高 2 例,持续性症状 6 例)。培养阳性复发患者的 CD4 计数(25 个细胞/μL;IQR:9-76)和 CSF 白细胞(WBC;4 个细胞/μL;IQR:4-85)计数均低于矛盾性 IRIS(CD4:78 个细胞/μL;IQR:47-142;WBC:45 个细胞/μL;IQR:8-128)。在 CSF WBC<5 个细胞/μL 的患者中,86%(43/50)为复发。在 CD4 计数<50 个细胞/μL 的患者中,91%(39/43)为复发。初次隐球菌性脑膜炎的 18 周死亡率(从当前症状发作开始计算)为 47%,培养阳性复发的死亡率为 31%,矛盾性 IRIS 的死亡率为 14%。
与 IRIS 相比,复发患者的免疫重建较差,表现为 CSF WBC 和血 CD4 计数较低。这些容易获得的实验室值应促使在等待培养结果的同时开始抗真菌治疗。
NCT01802385。